Latest News

Cellink AB to take-over Discover Echo Inc

© Discover Echo Inc.


by tg

Swedish Cellink AB has announced a bid of $110m to take over all shares of Discover Echo Inc., 11% of which to be paid in newly issued shares.

San Diego-based Discover Echo Inc. is  a specialist for unique hybrid automated microscopes that easily transform between upright (for viewing glass slides) and inverted configurations (for viewing live samples in petri dishes and well plates), merging the capabilities of multiple instruments into one. Cellink expects the company, which has a subsidiary in the UK, to grow 65% in 2021 and generate about $20m in revenues.

Discover Echo has a large growth potential in the bioprocessing industry where the CELLINK Group is a well-known supplier and has the ability to accelerate Discover Echo’s penetration in this sector. The US company has improved the usability of their microscopes by replacing traditional eyepieces with ultra high-resolution touchscreen displays and offering an intuitive software app that advances the workflow of acquiring, sharing, and analysing images.

"With the strategic acquisition of Discover Echo, we further strengthen our position within our Biosciences segment and we further complement our existing bioconvergence products and capture strong cross-selling synergies,” said Erik Gatenholm, CEO of Cellink AB.

LSP Dementia Fund closes at €260m

Investors included the Alzheimer’s Association, the European Investment Fund EIF, several unnamed global pharmaceutical, and insurance companies,...

Minaris and LIfT BioSciences collaborate in cell therapy development

LIfT BioSciences wants to start its first-in-human clinical trials with an allogeneic neutrophil progenitor-based cell therapy in first Quartal...

500 experts at the 7th AMR Conference in Basel

That antimicrobial resistance can no longer be considered a silent pandemic became abundantly clear at the AMR Conference in Basel from March 16-17....

New partnerships push InDevR for Series B financing

Investments into InDevR, Inc. came from New York-based Adjuvant Capital ($4m) and French bioMèrieux SA ($5m), which will enable the commercial...

Evonetix extends Series B financing to US$54m

According to Evonetix Ltd, a benchtop gene synthesis specialist, the investment, which also includes existing investors such as Molten Ventures,...

Evidence of deliberate climate damage

For decades, some members of the fossil fuel industry tried to convince the public that a causative link between fossil fuel use and climate warming...

Paleo raised € 12 m in Series A financing round

The financing round was led by DSM Venturing, Planet A Ventures along with Gimv, SFPIM Relaunch, Beyond Impact, and Siddhi Capital. The proceeds will...